Autoimmunity and Immune Dysregulation in Primary Immune Deficiency Disorders

Abstract

Primary immune deficiencies are often associated with autoimmune disease due to the dysregulation of the immune system as a whole. In many immune deficiencies, lymphocytes may be present but dysfunctional, allowing for the development of excessive autoreactivity and resultant autoimmune disease. Autoimmune polyendocrinopathy candidiasis and ectodermal dystrophy, autoimmune lymphoproliferative syndrome, immunodyregulation polyendocrinopathy enteropathy X-linked, IL-10/IL-10 receptor deficiencies, and PLCG2-associated antibody deficiency and immune dysregulation are disorders in which autoimmunity is a hallmark of the clinical disease presentation. In contrast, adaptive and innate immune deficiencies, which are typically defined by their infectious susceptibilities, can be associated with variable rates of autoimmune manifestations, predominantly autoimmune cytopenias. This review describes the immune dysregulation and autoimmune manifestations that may be encountered in various immune deficiencies.

This is a preview of subscription content, log in to check access.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.••

    Al-Herz W et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol. 2014;5:162. The most current and complete listing of primary immune deficiencies.

    PubMed Central  PubMed  Google Scholar 

  2. 2.

    Boyle JM, Buckley RH. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol. 2007;27:497–502.

    CAS  Article  PubMed  Google Scholar 

  3. 3.

    Zlotogora J, Shapiro MS. Polyglandular autoimmune syndrome type I among Iranian Jews. J Med Genet. 1992;29:824–6.

    CAS  Article  PubMed Central  PubMed  Google Scholar 

  4. 4.

    Rosatelli MC et al. A common mutation in Sardinian autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients. Hum Genet. 1998;103:428–34.

    CAS  Article  PubMed  Google Scholar 

  5. 5.

    Ahonen P, Myllarniemi S, Sipila I, Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med. 1990;322:1829–36.

    CAS  Article  PubMed  Google Scholar 

  6. 6.

    Puel A et al. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med. 2010;207:291–7.

    CAS  Article  PubMed Central  PubMed  Google Scholar 

  7. 7.

    Kisand K et al. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J Exp Med. 2010;207:299–308.

    CAS  Article  PubMed Central  PubMed  Google Scholar 

  8. 8.

    Perheentupa J. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab. 2006;91:2843–50.

    CAS  Article  PubMed  Google Scholar 

  9. 9.

    Husebye ES, Perheentupa J, Rautemaa R, Kampe O. Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I. J Intern Med. 2009;265:514–29.

    CAS  Article  PubMed  Google Scholar 

  10. 10.

    Kisand K et al. Mucocutaneous candidiasis and autoimmunity against cytokines in APECED and thymoma patients: clinical and pathogenetic implications. Eur J Immunol. 2011;41:1517–27.

    CAS  Article  PubMed  Google Scholar 

  11. 11.

    Sneller MC et al. Clinical, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood. 1997;89:1341–8.

    CAS  PubMed  Google Scholar 

  12. 12.

    Holzelova E et al. Autoimmune lymphoproliferative syndrome with somatic Fas mutations. N Engl J Med. 2004;351:1409–18.

    CAS  Article  PubMed  Google Scholar 

  13. 13.

    Magerus-Chatinet A et al. Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation. J Clin Invest. 2011;121:106–12.

    CAS  Article  PubMed Central  PubMed  Google Scholar 

  14. 14.

    Chun HJ et al. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature. 2002;419:395–9.

    CAS  Article  PubMed  Google Scholar 

  15. 15.

    Teachey DT. New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome. Curr Opin Pediatr. 2012;24:1–8.

    CAS  Article  PubMed Central  PubMed  Google Scholar 

  16. 16.

    Sneller MC, Dale JK, Straus SE. Autoimmune lymphoproliferative syndrome. Curr Opin Rheumatol. 2003;15:417–21.

    CAS  Article  PubMed  Google Scholar 

  17. 17.

    Oliveira JB et al. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Blood. 2010;116:e35–40.

    CAS  Article  PubMed Central  PubMed  Google Scholar 

  18. 18.

    Neven B et al. A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation. Blood. 2011;118:4798–807.

    CAS  Article  PubMed  Google Scholar 

  19. 19.

    Teachey DT et al. Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS). Blood. 2005;105:2443–8.

    CAS  Article  PubMed  Google Scholar 

  20. 20.

    Seif AE, Manno CS, Sheen C, Grupp SA, Teachey DT. Identifying autoimmune lymphoproliferative syndrome in children with Evans syndrome: a multi-institutional study. Blood. 2010;115:2142–5.

    CAS  Article  PubMed  Google Scholar 

  21. 21.

    Straus SE, Sneller M, Lenardo MJ, Puck JM, Strober W. An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome. Ann Intern Med. 1999;130:591–601.

    CAS  Article  PubMed  Google Scholar 

  22. 22.

    Bennett CL, Ochs HD. IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena. Curr Opin Pediatr. 2001;13:533–8.

    CAS  Article  PubMed  Google Scholar 

  23. 23.

    Gambineri E et al. Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity. J Allergy Clin Immunol. 2008;122:1105–12.

    CAS  Article  PubMed  Google Scholar 

  24. 24.

    Wildin RS, Smyk-Pearson S, Filipovich AH. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet. 2002;39:537–45.

    CAS  Article  PubMed Central  PubMed  Google Scholar 

  25. 25.

    Peake JE, McCrossin RB, Byrne G, Shepherd R. X-linked immune dysregulation, neonatal insulin dependent diabetes, and intractable diarrhoea. Arch Dis Child Fetal Neonatal Ed. 1996;74:F195–9.

    CAS  Article  PubMed Central  PubMed  Google Scholar 

  26. 26.

    Roifman CM. Human IL-2 receptor alpha chain deficiency. Pediatr Res. 2000;48:6–11.

    CAS  Article  PubMed  Google Scholar 

  27. 27.

    Sharfe N, Dadi HK, Shahar M, Roifman CM. Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor. Proc Natl Acad Sci U S A. 1997;94:3168–71.

    CAS  Article  PubMed Central  PubMed  Google Scholar 

  28. 28.

    Goudy K et al. Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity. Clin Immunol. 2013;146:248–61.

    CAS  Article  PubMed Central  PubMed  Google Scholar 

  29. 29.

    Bernasconi A et al. Characterization of immunodeficiency in a patient with growth hormone insensitivity secondary to a novel STAT5b gene mutation. Pediatrics. 2006;118:e1584–92.

    Article  PubMed  Google Scholar 

  30. 30.

    Cohen AC et al. Cutting edge: decreased accumulation and regulatory function of CD4+ CD25(high) T cells in human STAT5b deficiency. J Immunol. 2006;177:2770–4.

    CAS  Article  PubMed  Google Scholar 

  31. 31.

    Boisson-Dupuis S et al. Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes. Curr Opin Immunol. 2012;24:364–78.

    CAS  Article  PubMed Central  PubMed  Google Scholar 

  32. 32.

    Liu L et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med. 2011;208:1635–48.

    CAS  Article  PubMed Central  PubMed  Google Scholar 

  33. 33.•

    Uzel G et al. Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome. J Allergy Clin Immunol. 2013;131:1611–23. Describes an alternative phenotype for STAT1 GOF mutations, namely IPEX-like autoimmunity.

    CAS  Article  PubMed Central  PubMed  Google Scholar 

  34. 34.

    Glocker EO et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med. 2009;361:2033–45.

    CAS  Article  PubMed Central  PubMed  Google Scholar 

  35. 35.

    Glocker EO et al. Infant colitis—it’s in the genes. Lancet. 2010;376:1272.

    Article  PubMed  Google Scholar 

  36. 36.

    Kotlarz D et al. Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy. Gastroenterology. 2012;143:347–55.

    CAS  Article  PubMed  Google Scholar 

  37. 37.•

    Engelhardt KR et al. Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation. J Allergy Clin Immunol. 2013;131:825–30. Demonstrates failure of conventional antiinflammatory therapy vs disease resolution with HSCT in inflammatory bowel disease due to IL-10 signaling defects.

    CAS  Article  PubMed  Google Scholar 

  38. 38.•

    Ombrello MJ et al. Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions. N Engl J Med. 2012;366:330–8. Describes the new PLAID syndrome, also named FCAS3.

    CAS  Article  PubMed Central  PubMed  Google Scholar 

  39. 39.•

    Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood. 2012;119:1650–7. Identified lymphoma, hepatitis, inflammatory lung complications, and gastrointestinal disease as risk factors for increased mortality in CVID.

    CAS  Article  PubMed Central  PubMed  Google Scholar 

  40. 40.

    Chapel H et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood. 2008;112:277–86.

    CAS  Article  PubMed  Google Scholar 

  41. 41.

    Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999;92:34–48.

    CAS  Article  PubMed  Google Scholar 

  42. 42.

    Zhang L et al. Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes. J Allergy Clin Immunol. 2007;120:1178–85.

    CAS  Article  PubMed Central  PubMed  Google Scholar 

  43. 43.

    Quartier P et al. Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to activation-induced cytidine deaminase deficiency. Clin Immunol. 2004;110:22–9.

    CAS  Article  PubMed  Google Scholar 

  44. 44.

    Duarte-Rey C, Bogdanos DP, Leung PS, Anaya JM, Gershwin ME. IgM predominance in autoimmune disease: genetics and gender. Autoimmun Rev. 2012;11:A404–12.

    CAS  Article  PubMed  Google Scholar 

  45. 45.

    Jesus AA, Duarte AJ, Oliveira JB. Autoimmunity in hyper-IgM syndrome. J Clin Immunol. 2008;28 Suppl 1:S62–6.

    CAS  Article  PubMed  Google Scholar 

  46. 46.

    Lacroix-Desmazes S et al. Defective self-reactive antibody repertoire of serum IgM in patients with hyper-IgM syndrome. J Immunol. 1999;162:5601–8.

    CAS  PubMed  Google Scholar 

  47. 47.

    Lee AH, Levinson AI, Schumacher Jr HR. Hypogammaglobulinemia and rheumatic disease. Semin Arthritis Rheum. 1993;22:252–64.

    CAS  Article  PubMed  Google Scholar 

  48. 48.

    Edwards E, Razvi S, Cunningham-Rundles C. IgA deficiency: clinical correlates and responses to pneumococcal vaccine. Clin Immunol. 2004;111:93–7.

    CAS  Article  PubMed  Google Scholar 

  49. 49.

    Singh K, Chang C, Gershwin ME. IgA deficiency and autoimmunity. Autoimmun Rev. 2014;13:163–77.

    CAS  Article  PubMed  Google Scholar 

  50. 50.

    Cavadini P et al. AIRE deficiency in thymus of 2 patients with Omenn syndrome. J Clin Invest. 2005;115:728–32.

    CAS  Article  PubMed Central  PubMed  Google Scholar 

  51. 51.

    Cassani B et al. Defect of regulatory T cells in patients with Omenn syndrome. J Allergy Clin Immunol. 2010;125:209–16.

    CAS  Article  PubMed  Google Scholar 

  52. 52.

    Dupuis-Girod S et al. Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients. Pediatrics. 2003;111:e622–7.

    Article  PubMed  Google Scholar 

  53. 53.

    Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA. A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr. 1994;125:876–85.

    CAS  Article  PubMed  Google Scholar 

  54. 54.

    Adriani M et al. Impaired in vitro regulatory T cell function associated with Wiskott-Aldrich syndrome. Clin Immunol. 2007;124:41–8.

    CAS  Article  PubMed Central  PubMed  Google Scholar 

  55. 55.

    Marangoni F et al. WASP regulates suppressor activity of human and murine CD4(+)CD25(+)FOXP3(+) natural regulatory T cells. J Exp Med. 2007;204:369–80.

    CAS  Article  PubMed Central  PubMed  Google Scholar 

  56. 56.

    Nikolov NP et al. Systemic autoimmunity and defective Fas ligand secretion in the absence of the Wiskott-Aldrich syndrome protein. Blood. 2010;116:740–7.

    CAS  Article  PubMed Central  PubMed  Google Scholar 

  57. 57.

    Becker-Herman S et al. WASp-deficient B cells play a critical, cell-intrinsic role in triggering autoimmunity. J Exp Med. 2011;208:2033–42.

    CAS  Article  PubMed Central  PubMed  Google Scholar 

  58. 58.

    Recher M et al. B cell-intrinsic deficiency of the Wiskott-Aldrich syndrome protein (WASp) causes severe abnormalities of the peripheral B-cell compartment in mice. Blood. 2012;119:2819–28.

    CAS  Article  PubMed Central  PubMed  Google Scholar 

  59. 59.

    Catucci M, Castiello MC, Pala F, Bosticardo M, Villa A. Autoimmunity in Wiskott-Aldrich syndrome: an unsolved enigma. Front Immunol. 2012;3:209.

    Article  PubMed Central  PubMed  Google Scholar 

  60. 60.

    Walport MJ, Davies KA, Botto M. C1q and systemic lupus erythematosus. Immunobiology. 1998;199:265–85.

    CAS  Article  PubMed  Google Scholar 

  61. 61.

    Pickering MC, Walport MJ. Links between complement abnormalities and systemic lupus erythematosus. Rheumatology (Oxford). 2000;39:133–41.

    CAS  Article  Google Scholar 

  62. 62.

    Barilla-LaBarca ML, Atkinson JP. Rheumatic syndromes associated with complement deficiency. Curr Opin Rheumatol. 2003;15:55–60.

    CAS  Article  PubMed  Google Scholar 

  63. 63.

    Jonsson G et al. Rheumatological manifestations, organ damage and autoimmunity in hereditary C2 deficiency. Rheumatology (Oxford). 2007;46:1133–9.

    CAS  Article  Google Scholar 

  64. 64.

    Ogden CA et al. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med. 2001;194:781–95.

    CAS  Article  PubMed Central  PubMed  Google Scholar 

  65. 65.

    Davies KA et al. Splenic uptake of immune complexes in man is complement-dependent. J Immunol. 1993;151:3866–73.

    CAS  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Dr Lehman declares no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Heather K. Lehman.

Additional information

This article is part of the Topical Collection on Basic and Applied Science

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Lehman, H.K. Autoimmunity and Immune Dysregulation in Primary Immune Deficiency Disorders. Curr Allergy Asthma Rep 15, 53 (2015). https://doi.org/10.1007/s11882-015-0553-x

Download citation

Keywords

  • Autoimmunity
  • Primary immune deficiency diseases
  • Immune dysregulation